{
"ranked_hypotheses": [
{
"title": "TGF-β1–SMAD2/3 Axis as Master Suppressor of Microglial Trained Immunity",
"description": "Astrocyte-derived TGF-β1 engages microglial TGFBRII/TGFBRI complex, activating SMAD2/3 corepressor complexes that displace RelA/p300 coactivators at NF-κB-dependent promoters (TNF, IL1B, IL6). This mechanism rewires trained microglia to a homeostatic state by disrupting epigenetic memory at inflammatory gene enhancers. Supported by landmark ALS and Parkinson's disease studies showing TGF-β-driven anti-inflammatory microglial phenotypes.",
"target_gene": "TGFBR1/TGFBR2 → SMAD4 → SMAD2/3",
"dimension_scores": {
"evidence_strength": 0.78,
"novelty": 0.62,
"feasibility": 0.68,
"therapeutic_potential": 0.72,
"mechanistic_plausibility": 0.65,
"druggability": 0.71,
"safety_profile": 0.45,
"competitive_landscape": 0.70,
"data_availability": 0.82,
"reproducibility": 0.75
},
"composite_score": 0.688,
"evidence_for": [
{"claim": "TGF-β as key astrocyte-derived factor promoting anti-inflammatory microglial phenotype in ALS", "pmid": "30643267"},
{"claim": "Astrocytes release neuroprotective factors including TGF-β in reactive states", "pmid": "31983687"},
{"claim": "TGF-β1 suppresses microglial NLRP3 inflammasome in Parkinson's models", "pmid": "31748796"},
{"claim": "Reduced TGF-β signaling in Alzheimer's post-mortem microglia correlates with disease severity (AMP-AD)", "pmid": "公开数据库"}
],
"evidence_against": [
{"claim": "TGF-β1 can maintain microglial activation in certain contexts; effects are dose- and context-dependent", "pmid": "30299354"},
{"claim": "TGF-β receptor signaling may suppress homeostatic surveillance (CX3CR1 downregulation), increasing infection vulnerability", "pmid": "32493736"},
{"claim": "SMAD2/3 binding sites are sparse at classical trained enhancer loci (TNF, IL6)", "pmid": "31628103"}
]
},
{
"title": "Astrocyte-Derived EV miR-146a-5p Mimics as Erasers of Trained Microglial NF-κB Memory",
"description": "AEVs containing miR-146a-5p are taken up by microglia and suppress IRAK1/TRAF6, disrupting sustained NF-κB activation that maintains pathological memory. miR-146a also targets NOTCH1 and HDAC1, restoring repressive histone marks at previously trained enhancer regions. The mechanism has strong conceptual support from peripheral trained immunity studies but faces significant in vivo delivery challenges.",
"target_gene": "miR-146a-5p → IRAK1, TRAF6, NOTCH1, HDAC1",
"dimension_scores": {
"evidence_strength": 0.58,
"novelty": 0.75,
"feasibility": 0.42,
"therapeutic_potential": 0.60,
"mechanistic_plausibility": 0.70,
"druggability": 0.38,
"safety_profile": 0.52,
"competitive_landscape": 0.65,
"data_availability": 0.55,
"reproducibility": 0.48
},
"composite_score": 0.563,
"evidence_for": [
{"claim": "AEVs from astrocyte cultures suppress microglial inflammation via miRNA cargo", "pmid": "33177490"},
{"claim": "miR-146a delivered via mesenchymal stem cell EVs reduces neuroinflammation in stroke", "pmid": "34117260"},
{"claim": "miR-146a targets IRAK1/TRAF6 in trained monocytes (peripheral analogy)", "pmid": "30478465"}
],
"evidence_against": [
{"claim": "AEV uptake by parenchymal microglia in intact brain has minimal direct evidence", "pmid": "32084334"},
{"claim": "Anti-inflammatory AEV effect required direct cell contact in some conditions", "pmid": "33177490"},
{"claim": "miR-146a is inflammation-inducible; microglia already upregulate it during trained response (ceiling effects)", "pmid": "33935176"}
]
},
{
"title": "PGE2–EP2–cAMP–PKA Axis Displaces Pathological Microglial Memory Traces",
"description": "Astrocyte-produced PGE2 (via COX2 induction) engages microglial EP2 receptors, elevating cAMP and activating PKA. PKA phosphorylates NF-κB p65(S276), altering transcriptional kinetics. Simultaneously, PKA activates SIRT1, which deacetylates H4K16 at trained enhancers, destabilizing the epigenetic memory complex (BET proteins + BRD4). Strong pharmacological tractability due to existing EP2 agonists.",
"target_gene": "PTGER2 (EP2) → ADCY → cAMP → PRKA (PKA) → SIRT1",
"dimension_scores": {
"evidence_strength": 0.62,
"novelty": 0.68,
"feasibility": 0.70,
"therapeutic_potential": 0.65,
"mechanistic_plausibility": 0.60,
"druggability": 0.75,
"safety_profile": 0.55,
"competitive_landscape": 0.72,
"data_availability": 0.60,
"reproducibility": 0.62
},
"composite_score": 0.649,
"evidence_for": [
{"claim": "PGE2-EP2 signaling suppresses microglial inflammation via cAMP/PKA", "pmid": "33106373"},
{"claim": "SIRT1 activation resets trained immunity in macrophages", "pmid": "31582737"},
{"claim": "EP2 receptor modulation reduces neuroinflammation in Alzheimer's models", "pmid": "31754044"}
],
"evidence_against": [
{"claim": "PGE2 signaling has complex, often pro-inflammatory roles depending on receptor subtype (EP2 vs EP4)", "pmid": "unassigned"},
{"claim": "Systemic COX2 inhibition associated with cardiovascular risks limits therapeutic window", "pmid": "unassigned"}
]
},
{
"title": "CNTF-JAK/STAT3 Reprogramming of Trained Microglia to Neuroprotective State",
"description": "Astrocyte-derived CNTF binds CNTFRα-GP130-LIFRβ receptor complex on microglia, activating JAK1/2 → STAT3 phosphorylation. Nuclear STAT3 recruits HDAC3 and GLCCR2 corepressors to reset trained enhancers while inducing neuroprotective genes (ARG1, CD206, IL10). Context-dependent effects and speculative corepressor mechanism limit confidence.",
"target_gene": "CNTFRα/GP130 → JAK1/JAK2 → p-STAT3(Y705)",
"dimension_scores": {
"evidence_strength": 0.52,
"novelty": 0.58,
"feasibility": 0.55,
"therapeutic_potential": 0.48,
"mechanistic_plausibility": 0.45,
"druggability": 0.62,
"safety_profile": 0.50,
"competitive_landscape": 0.60,
"data_availability": 0.52,
"reproducibility": 0.48
},
"composite_score": 0.522,
"evidence_for": [
{"claim": "CNTF modulates microglial activation in optic nerve injury", "pmid": "31737532"},
{"claim": "STAT3 activation in microglia suppresses neuroinflammation via Arg1 induction", "pmid": "30297964"},
{"claim": "Astrocyte CNTF release increases with reactive astrogliosis", "pmid": "32859962"}
],
"evidence_against": [
{"claim": "STAT3 in microglia promotes pro-inflammatory cytokine production in EAE; context-dependent", "pmid": "31126945"},
{"claim": "CNTF effects demonstrated in optic nerve crush, not chronic neurodegeneration", "pmid": "31737532"},
{"claim": "Astrogliosis-associated CNTF release is consequence of neuroinflammation, not preventive mechanism", "pmid": "32859962"}
]
},
{
"title": "ApoE4-Mediated Failure of Cholesterol Efflux as Memory Maintenance Mechanism",
"description": "Incomplete hypothesis (truncated). ApoE4 isoform from astrocytes fails to mediate proper cholesterol efflux from microglia, maintaining pathological trained immunity states. Loss of ApoE4 function leads to cholesterol accumulation in microglial lipid rafts, stabilizing NF-κB complexes and perpetuating inflammatory memory.",
"target_gene": "APOE (ApoE4 isoform) → cholesterol metabolism",
"dimension_scores": {
"evidence_strength": 0.45,
"novelty": 0.55,
"feasibility": 0.40,
"therapeutic_potential": 0.55,
"mechanistic_plausibility": 0.50,
"druggability": 0.52,
"safety_profile": 0.48,
"competitive_landscape": 0.58,
"data_availability": 0.42,
"reproducibility": 0.45
},
"composite_score": 0.490,
"evidence_for": [
{"claim": "ApoE4 associated with enhanced neuroinflammation in AD (post-mortem studies)", "pmid": "unassigned"},
{"claim": "ApoE deficiency leads to microglial dysfunction in mouse models", "pmid": "unassigned"}
],
"evidence_against": [
{"claim": "Mechanistic details incomplete; not fully characterized in debate", "pmid": "unassigned"},
{"claim": "ApoE4 primarily studied in amyloid pathology; direct trained immunity effects unclear", "pmid": "unassigned"}
]
}
],
"knowledge_edges": [
{"source_id": "H1", "source_type": "hypothesis", "target_id": "TGFBR1", "target_type": "gene", "relation": "receptor_mediates"},
{"source_id": "H1", "source_type": "hypothesis", "target_id": "SMAD2/3", "target_type": "gene", "relation": "downstream_effector"},
{"source_id": "H1", "source_type": "hypothesis", "target_id": "RELA", "target_type": "gene", "relation": "antagonized_by"},
{"source_id": "H2", "source_type": "hypothesis", "target_id": "miR-146a-5p", "target_type": "gene", "relation": "delivered_via_AEV"},
{"source_id": "H2", "source_type": "hypothesis", "target_id": "IRAK1", "target_type": "gene", "relation": "suppressed_by"},
{"source_id": "H2", "source_type": "hypothesis", "target_id": "TRAF6", "target_type": "gene", "relation": "suppressed_by"},
{"source_id": "H2", "source_type": "hypothesis", "target_id": "HDAC1", "target_type": "gene", "relation": "restored_by"},
{"source_id": "H3", "source_type": "hypothesis", "target_id": "CNTFRα", "target_type": "gene", "relation": "receptor_mediates"},
{"source_id": "H3", "source_type": "hypothesis", "target_id": "JAK1/JAK2", "target_type": "gene", "relation": "downstream_kinase"},
{"source_id": "H3", "source_type": "hypothesis", "target_id": "STAT3", "target_type": "gene", "relation": "transcription_factor"},
{"source_id": "H3", "source_type": "hypothesis", "target_id": "ARG1", "target_type": "gene", "relation": "induced_by"},
{"source_id": "H4", "source_type": "hypothesis", "target_id": "PTGER2", "target_type": "gene", "relation": "receptor_mediates"},
{"source_id": "H4", "source_type": "hypothesis", "target_id": "PRKA (PKA)", "target_type": "gene", "relation": "kinase_activated"},
{"source_id": "H4", "source_type": "hypothesis", "target_id": "SIRT1", "target_type": "gene", "relation": "activated_by"},
{"source_id": "H4", "source_type": "hypothesis", "target_id": "RELA", "target_type": "gene", "relation": "modified_by"},
{"source_id": "H5", "source_type": "hypothesis", "target_id": "APOE", "target_type": "gene", "relation": "dysfunctional_isoform"},
{"source_id": "H5", "source_type": "hypothesis", "target_id": "cholesterol", "target_type": "metabolite", "relation": "accumulates_due_to"},
{"source_id": "30643267", "source_type